TuHURA Biosciences, Inc. HURA Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $0— | $0— | $0— | $0— | $0— | ||
| $21.18M+3.2% | $20.53M+11.3% | $18.45M+12.3% | $16.43M+14.7% | $14.33M+7.4% | ||
| —— | —— | $10M+10.8% | $9.03M+85.2% | $4.87M+25.8% | ||
| $32.31M+1.6% | $31.8M+8.5% | $29.32M+11.4% | $26.32M+31.2% | $20.06M+13.7% | ||
| —— | —— | —— | —— | —— | ||
| $1.38M-20.6% | $1.74M-58.4% | $4.19M-9.1% | $4.62M+76.4% | $2.62M+11.9% | ||
| -$30.92M-2.9% | -$30.05M-2.6% | -$29.29M-5.5% | -$27.76M-18.1% | -$23.5M-8.4% | ||
| -$0.61+3.2% | -$0.63— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is TuHURA Biosciences, Inc. profitable?
- TuHURA Biosciences, Inc. is not currently profitable: it reported a net loss of $30.9M over the trailing twelve months.
- What is TuHURA Biosciences, Inc.'s earnings per share?
- TuHURA Biosciences, Inc.'s diluted EPS over the trailing twelve months is $-0.61.
- Where does TuHURA Biosciences, Inc.'s income statement data come from?
- Every line is extracted from TuHURA Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.